ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 212446 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 212446; 2) Community: the network communities that were significantly associated with the response to NSC 212446; 3) Molecule: the relationships between components within communities and NSC 212446; 4) MDR: the compounds that were significantly associated with the NSC 212446.

NSC Compound Enrichment Correlation
NSC 176328 Ellipticine, 6-(3-aminopropyl)-, dihydrochloride 0.00578566967432527 0.47372737
NSC 266046 Oxaliplatin 0.00640068043275774 0.591786
NSC 275971 Null 0.00640068043275774 0.41876201
NSC 6926 Null 0.00640068043275774 0.32273166
NSC 709974 Null 0.00640068043275774 0.42297677
NSC 718781 Erlotinib hydrochloride 0.00640068043275774 -0.26069319
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.00640068043275774 -0.016588514
NSC 726217 Combretastatin A4-analogue 0.00640068043275774 0.38743764
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.00640068043275774 0.21420843
NSC 732205 Null 0.00640068043275774 0.26594502
Total:135  Current:32    [First] [Prev] [Next] [Last]